mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |